Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | HTT | P42858 | 1/20 | 0.69 |
| ▸ | NAAA | Q02083 | 4/20 | 0.67 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | DRD2 | P14416 | 1/20 | 0.54 |
| ▸ | DRD4 | P21917 | 1/20 | 0.54 |
| ▸ | DRD3 | P35462 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 3/20 | 0.52 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL21827420 | 0.91 | TSHR (0.57) | TSHRHTTNAAAHPGDDRD2 | |
| SCHEMBL11078107 | 0.89 | HTT (0.86) | TSHRHTTNAAAHPGDALDH1A1 | |
| SCHEMBL11089468 | 0.89 | HTT (0.86) | TSHRHTTNAAAHPGDALDH1A1 | |
| SCHEMBL9260536 | 0.89 | HTT (0.86) | TSHRHTTNAAAHPGDALDH1A1 | |
| SCHEMBL5362359 | 0.89 | HTT (0.86) | TSHRHTTNAAAHPGDALDH1A1 | |
| Trolamine SCHEMBL8963359 | 0.88 | HTT (0.60) | TSHRHTTNAAAHPGDDRD2 | |
| Trolamine SCHEMBL9091920 | 0.88 | HTT (0.60) | TSHRHTTNAAAHPGDDRD2 | |
| Trolamine SCHEMBL9089511 | 0.88 | HTT (0.60) | TSHRHTTNAAAHPGDDRD2 | |
| SCHEMBL12704467 | 0.87 | NAAA (0.74) | TSHRHTTNAAAHPGDDRD2 | |
| SCHEMBL11267483 | 0.86 | HPGD (0.68) | TSHRHTTNAAAHPGDDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112639050-B | Asymmetrically substituted diamido ammonium dicarboxylic acid salts and their use for antiagglomerating gas hydrates | 科莱恩国际有限公司 | 2022-11-01 | — | — | CN | disclosed |
| EP-3864108-B1 | UNSYMMETRICALLY SUBSTITUTED DICARBOXYLIC ACID DIAMIDO AMMONIUM SALTS AND THEIR USE FOR GAS HYDRATE ANTI-AGGLOMERATION | CLARIANT INT LTD (CH) | 2022-06-15 | — | — | EP | disclosed |
| US-11161804-B2 | Unsymmetrically substituted dicarboxylic acid diamido ammonium salts and their use for gas hydrate anti-agglomeration | CLARIANT INTERNATIONAL LTD. (CH) | 2021-11-02 | — | — | US | disclosed |
| EP-3864108-A1 | UNSYMMETRICALLY SUBSTITUTED DICARBOXYLIC ACID DIAMIDO AMMONIUM SALTS AND THEIR USE FOR GAS HYDRATE ANTI-AGGLOMERATION | Clariant International Ltd (CH) | 2021-08-18 | — | — | EP | disclosed |
| CN-112639050-A | Asymmetrically substituted diamido ammonium dicarboxylic acid salts and their use for antiagglomerating gas hydrates | 科莱恩国际有限公司 | 2021-04-09 | — | — | CN | disclosed |
| US-20200109107-A1 | Unsymmetrically Substituted Dicarboxylic Acid Diamido Ammonium Salts And Their Use For Gas Hydrate Anti-Agglomeration | CLARIANT INTERNATIONAL, LTD. (CH) | 2020-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200109107-A1 | Unsymmetrically Substituted Dicarboxylic Acid Diamido Ammonium Salts And Their Use For Gas Hydrate Anti-Agglomeration | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, SLC9A5, NUP205 | TSHR 3176/4885HTT 1370/4885NAAA 218/4885 |
| US-11161804-B2 | Unsymmetrically substituted dicarboxylic acid diamido ammonium salts and their use for gas hydrate anti-agglomeration | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, SLC9A5, NUP205 | TSHR 3162/4885HTT 1366/4885NAAA 210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.